Medical Device Batteries: Focus on Implants and Wearable Medical Devices by Roots Analysis

 

An exponential increase in development efforts related to wearable medical devices and implants, has fueled a corresponding rise in demand for safe, compact, light-weight and high energy density batteries with longer life span

 

Roots Analysis has announced the addition of “Medical Device Batteries: Focus on Implants and Wearable Medical Devices - Market Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others), Rechargeability (Rechargeable and Non-Rechargeable), Application (Hearing Aids, Patient Monitoring Devices, Drug Delivery Devices, Cardiovascular Medical Devices and Others) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2020-2030” report to its list of offerings.

 

Battery-operated medical devices, such as cochlear implants, defibrillators, insulin pumps and pacemakers, have redefined 21st century healthcare, adding to the user convenience factor and offering profitable value propositions for developers. Battery technologies have simultaneously evolved, with modern power-storage cells having improved safety features and the potential to be used for longer durations.

 

To order this 190+ page report, which features 60+ figures and 90+ tables, please visit this - https://www.rootsanalysis.com/reports/medical-device-batteries-market.html

 

Key Market Insights

 

More than 930 batteries, designed for use in medical devices, are currently available / under development

More than 75% of the aforementioned batteries that are intended for implants and wearable medical devices, have lithium based chemistries. The majority of batteries captured in the report (62%) are intended for hearing aids; this is followed by those used in patient monitoring devices (17%) and drug delivery devices (12%).

 

Over 50 companies, across the world, claim to be engaged in developing medical device batteries

Majority (45%) of these battery developers are located in the Asia Pacific region, primarily in China, while Europe (29%) and North America (27%) almost have an equal number of innovators focused in this field. More than 40% of the industry stakeholders are very large firms.

 

330+ patents related to medical device batteries have been filed since 2015 
R&D activity related to medical device batteries is largely concentrated in the US, considering that more than 35% of the total number of patents were filed in this region. Around 70% of intellectual property related filings in this field were observed to focused on batteries intended for implantable devices.

 

North America and Europe are anticipated to capture close to 50% market share, by 2030

On the other hand, Asia Pacific is expected to witness a higher growth rate as compared to other geographies due to the advancement in healthcare facilities. Currently, the market is driven by the sales of medical device batteries designed for wearable medical device (75%), followed by those intended to power implantable devices (25%). Further, rechargeable medical device batteries currently capture 25% of the overall market share (in terms of sales revenues).

 

To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/medical-device-batteries-market/request-sample.html

 

Key Questions Answered

§  What kind of batteries are currently available / under development for different types of medical devices?

§  Who are the leading developers of medical device batteries?

§  What are the key applications of medical device batteries in the modern healthcare industry?

§  Who are the most likely partners for medical device battery developers?

§  How is the intellectual property landscape in this field likely to evolve in the foreseen future?

§  What are the factors that are likely to influence the market’s evolution?

§  How is the current and future opportunity likely to be distributed across key market segments?

 

The USD XX billion (by 2030) financial opportunity within the medical device batteries market has been analyzed across the following segments:

§  Battery Chemistry

  • Lithium based
  • Zinc Air based
  • Nickel based
  • Others

 

§  Type of Device

  • Implantable
  • Wearable

 

§  Rechargeability

  • Rechargeable
  • Non-Rechargeable

 

§  Application

  • Hearing Aids
  • Patient Monitoring Devices
  • Drug Delivery Devices
  • Cardiovascular Medical Devices
  • Others

 

§  Key Geographical Regions 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World 

 

The research includes detailed profiles of key players (listed below) engaged in the development of medical device batteries; each profile features an overview of the developer, its financial information (if available), recent developments and an informed future outlook.

§  Blue Spark Technologies

§  CAMELION

§  EaglePicher Technologies

§  Energizer Holdings

§  Guangzhou Battsys

§  Murata

§  Panasonic

§  Renata

§  Tadiran Batteries

§  Toshiba

§  Ultralife

§  VARTA Microbattery

 

For additional details, please visit https://www.rootsanalysis.com/reports/medical-device-batteries-market.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.     Global Handheld X-Ray Imaging Devices Market

2.     Diabetes Monitoring Devices Market

3.     Inhaled and Intranasal Products Contract Service Providers Market

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.Chaudhary@rootsanalysis.com

Comments

Post a Comment

Popular posts from this blog

The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

    The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “ Microbial Contract Biomanufacturing Market, 2020-2030 ” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various...
Read more

Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 by Roots Analysis

  Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some of the key...
Read more

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more